TE
科技回声
首页24小时热榜最新最佳问答展示工作
GitHubTwitter
首页

科技回声

基于 Next.js 构建的科技新闻平台,提供全球科技新闻和讨论内容。

GitHubTwitter

首页

首页最新最佳问答展示工作

资源链接

HackerNews API原版 HackerNewsNext.js

© 2025 科技回声. 版权所有。

FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

3 点作者 mudil8 个月前

1 comment

reify8 个月前
not developed out of altruism or care for those struggling with schizophrenia.<p>In 2024, Bristol Myers Squibb purchased the drug from Karuna for US$14 billion.<p>Bristol Myers Squibb set the wholesale cost of the combo at $1,850 a month.<p>The effectiveness of xanomeline&#x2F;trospium chloride for the treatment of schizophrenia in adults was evaluated in two studies with identical designs.<p>Study 1 and study 2 were 5-week, randomized, double-blind, placebo-controlled, multi-center studies in adults with a diagnosis of schizophrenia according to DSM-5 criteria.<p>I am fully aware that all antipsychotics are basically chemical coshes and there is no evidence that they actually work to cure psychiatric illnesses in the long term.